Best Form of Ginkgo Biloba: How to Choose
Ginkgo biloba is one of the oldest botanical supplements in use, valued for its association with cognitive support and circulation. Yet the market offers several distinct ginkgo biloba forms — and not all are equivalent. Understanding these differences helps you spend wisely and achieve consistent results.
Forms Compared
| Form | Typical Ginkgo Flavonol Glycosides | Terpene Lactones | Notes |
|---|---|---|---|
| Standardised dry extract (EGb 761 / 24/6) | ~24% | ~6% | Most studied form |
| Non-standardised powdered leaf | Variable | Variable | Inconsistent potency |
| Leaf tea / infusion | Low | Very low | Mainly traditional use |
| Liquid extract (tincture) | Varies by brand | Varies | Convenience, but standardisation rare |
The standardised dry extract is the form used in virtually all human clinical trials. It is characterised by a minimum of 24% ginkgo flavonol glycosides and 6% terpene lactones — the two compound classes believed responsible for biological activity.
Non-standardised leaf powder and teas can contain widely variable amounts of active constituents and should not be assumed equivalent to the standardised extract.
Bioavailability Differences
Leaf preparations deliver far lower and less reproducible plasma levels because the active compound concentrations in the raw leaf vary significantly depending on harvest time, geographic origin, and processing.
Cost per Effective Dose
Clinical trials have predominantly used doses in the range of 120–240 mg of standardised extract daily, split into two or three servings. Products such as MST Ginkgo Biloba 60caps, OstroVit Ginkgo Biloba Extract 50g, and
BIOTECHUSA Ginkgo Biloba€18.90 In stock 90tabs — available at maxfit.ee — deliver clearly labelled extract concentrations, making it straightforward to calculate your actual daily intake.
By contrast, leaf teas or non-standardised powders make cost-per-effective-dose calculations difficult because the active content is unknown. In practice, standardised capsules typically offer better value when you factor in predictability.
Which Form for Which Goal?
Cognitive support and memory: All positive clinical evidence relates to the standardised extract (24/6 ratio). Choose capsules or tablets with clearly stated EGb 761 or equivalent standardisation.
Circulation and extremity comfort: Again, standardised extract. The terpene lactone fraction (particularly bilobalide and ginkgolides) is thought to underlie many vascular effects, and this fraction is absent or negligible in leaf teas.
Occasional/traditional use: A leaf tea is a pleasant beverage with a long history of use in East Asia. It is not a substitute for a clinical dose of standardised extract, but it causes no harm and may be enjoyable as part of a herbal routine.
Budget shoppers: Bulk powders of standardised extract can reduce per-dose cost, but confirm the extract ratio on the label before buying.
What to Look for on the Label
- Standardisation statement: Look for "standardised to 24% ginkgo flavonol glycosides and 6% terpene lactones" or EGb 761 / Li 1370 branding. These are the forms used in peer-reviewed research.
- Actual extract quantity per serving: Confirm the milligrams of extract, not milligrams of raw leaf equivalent.
- Absence of ginkgolic acids: Quality extracts should contain very low ginkgolic acid content (typically stated as <5 ppm), as high levels have been associated with tolerability issues.
- Third-party certification: GMP certification or independent testing for heavy metals and contaminants is a useful quality signal for any botanical supplement.
FAQ
What is the most studied form of ginkgo biloba?
The most studied form is the standardised dry extract EGb 761, characterised by 24% ginkgo flavonol glycosides and 6% terpene lactones. This is the form used in the large majority of clinical trials investigating cognitive and circulatory outcomes.
Can I get the same effect from ginkgo biloba tea?
Unlikely. Leaf teas deliver very low and highly variable concentrations of the active compounds compared to standardised extracts. For any goal linked to the research literature, a standardised capsule or tablet is the appropriate choice.
How long should I take ginkgo biloba before expecting results?
Most trials report assessments after four to twelve weeks of continuous use. Short-term single doses have been studied for acute cognitive measures, but sustained supplementation with a standardised extract is the approach supported by the weight of evidence.
References
Kanowski, S., Herrmann, W. M., Stephan, K., Wierich, W., & Horr, R. (1996). Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry, 29(2), 47-56. https://pubmed.ncbi.nlm.nih.gov/8741021/
Mazza, M., Capuano, A., Bria, P., & Mazza, S. (2006). Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. European Journal of Neurology, 13(9), 981-985. https://pubmed.ncbi.nlm.nih.gov/16930364/




